Can Early Detection Solutions Push the Tuberculosis Diagnostics Market to be Worth $3.56 Billion by 2031?


Posted September 16, 2024 by Pratiksha

Delve into the Tuberculosis Diagnostics Market, which is expected to hit $3.56 billion by 2031, with a projected CAGR of 5% from 2024. Learn about the factors driving this growth and the innovative trends that are set to transform the industry.
 
A new market research report from Meticulous Research®, titled ‘Tuberculosis Diagnostics Market Size, Share, Forecast, & Trends Analysis by Test Type, End User, Infection Stage – Global Forecast to 2031’, estimates that the tuberculosis diagnostics market will reach $3.56 billion by 2031, growing at a CAGR of 5.0% from 2024 to 2031.

Request For Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5885?

Key Growth Factors
The rise in the global prevalence of tuberculosis, especially in low- and middle-income countries, has become a significant growth driver for the market. The development of drug-resistant TB strains and the implementation of government initiatives to control tuberculosis further bolster the market's expansion. Awareness programs initiated by governments and organizations also play a crucial role in driving demand for tuberculosis diagnostic solutions.

Key Companies in the Market
Prominent players in the market include F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), Abbott Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN GmbH (Germany), Hologic, Inc. (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), Oxford Immunotec Ltd. (U.K.), Hain Lifescience GmbH (Germany), Creative Diagnostics (U.S.).

Market Segmentation and Future Outlook
The report segments the market based on test type, infection stage, end user, and geography. Additionally, it provides competitive analysis and country-level insights for various regions.

Test Type Overview
Among the test types, skin test/Mantoux is expected to account for the largest market share, with 38.2% in 2024. This dominance is due to the low cost, simplicity, and accessibility of the test, even in remote regions. The high adoption of skin tests for detecting latent TB infection also contributes to the segment's large share. Skin tests are cost-effective, with prices ranging from USD 37 for the Mantoux test to USD 89 for IGRA tests.

Infection Stage Insights
Based on infection stage, the market is divided into active and latent tuberculosis. The active tuberculosis segment is anticipated to experience the fastest growth rate during the forecast period. This growth is driven by the increasing incidence of active tuberculosis, particularly in low-income countries, and the efforts of governments and organizations to combat the disease.

End User Analysis
The market is segmented by end user into diagnostic laboratories, hospitals & clinics, academic & research institutes, and other end users. Diagnostic laboratories are expected to record the highest growth rate during the forecast period, thanks to the adoption of advanced diagnostic technologies and the capacity to handle complex tests like next-generation sequencing. Government-led efforts to raise awareness of tuberculosis further drive demand for laboratory diagnostics.

Asia-Pacific to Lead the Market Growth:
Asia-Pacific Growth Potential
The report highlights Asia-Pacific as the region with the highest projected growth. In particular, India and China are poised to offer significant market opportunities due to their high TB prevalence and growing investments in healthcare. Rising healthcare infrastructure and the countries’ large populations contribute to increasing demand for tuberculosis diagnostic solutions, making the region a critical area for market players.

India and China Leading the Market
Within Asia-Pacific, countries like India and China present lucrative growth opportunities for market players. The large populations and high TB burden in these nations are the primary factors driving demand for diagnostic tools and technologies. Moreover, both countries are experiencing economic growth, which has led to increased healthcare investments and the development of healthcare infrastructure, further supporting the expansion of the tuberculosis diagnostics market.

Buy Now: https://www.meticulousresearch.com/Checkout/14457940?

About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Meticulous Research
Phone 07447780008
Business Address Office No-202, 203,204,205,206; 2nd Floor, Pushpak Business Hub, Pune, Wakad, Pimpri-Chinchwad, Maharashtra 411057
Country India
Categories Health , Medical , Research
Last Updated September 16, 2024